-
Increased iron stores (eg, ferritin levels) are associated with an increased risk of type 2 diabetes in women.
-
The first of a class of calcimimetics has been approved by the FDA for the treatment of hyperparathyroidism associated with renal failure and in patients with parathyroid cancer.
-
These data provide further support that inflammation in general and periodontal disease more specifically are stroke risk factors.
-
High-dose atorvastatin protects patients with acute coronary syndrome from death and major cardiovascular events better than usual dose pravastatin.
-
Data supporting associations of subclinical thyroid disease with symptoms or adverse clinical outcomes or benefits of treatment are few.
-
Graded activity can return a patient to full employment faster than usual care.
-
Current rofecoxib use was associated with a higher risk of acute myocardial infarction or admission for heart failure compared to celecoxib.
-
Among patients with early, localized prostate cancer, the mortality rate accelerated after 15 years.
-
A randomized, controlled trial of obese men, ages 35 to 55, with erectile dysfunction showed that weight loss and increased physical activity allowed 31% to regain sexual function and most reduced their cardiac risk factors.
-
Patients are desperately looking for weight loss plans that do not involve consuming fewer calories or burning more of them. Perhaps they should be told about the relationship between sleep, weight, and
appetite.
